Apotheken
|
Arzt
|
Interaktionen
|
Medikamente
|
MiGeL
|
Services
|
Spital
|
Zulassungsi.
Home
<
Liste für "D07A" (54)
–
Sortierung nach Stärke, Packung und Preis
Preisvergleich
Preisvergleich und Inhaltsstoff
Markenname
Inhaltsstoff
Zulassungsinhaber
Anwendung
Interaktion
Unerwünschte Wirkung
Swissmedic-# (5-stellig)
Pharmacode
Präparat
Packungsgrösse
EFP
PP
SB
TK
Zusammensetzung
Zulassungsinhaber
Kat.
Was ist ein ATC-Code?
Zur ATC-Übersicht
Hydrocortison (D07AA02) 1 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Sanadermil
15 g
PA
PA
k.A.
Hydrocrème: Hydrocortisoni Acetas 5 mg
VERFORA SA
D
FB
G
Clobetason (D07AB01) 1 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Emovate
30 g
3.08
12.60
10%
Crème: Clobetasoni-17 Butyras
GlaxoSmithKline AG
B / SL
FB
G
Hydrocortisonbutyrat (D07AB02) 3 Präparate
WHO-DDD
FI
PI
Locoid
30 g
3.59
13.15
10%
Crème: Hydrocortisoni-17 Butyras 1 mg
Cheplapharm Schweiz
GmbH
● 
B / SL
FB
G
FI
PI
Locoid Crelo
30 g
4.53
14.15
10%
Emulsion: Hydrocortisoni-17 Butyras 1 mg/g
Cheplapharm Schweiz
GmbH
● 
B / SL
FB
G
FI
PI
Locoid Crelo
100 g
11.48
28.90
10%
Emulsion: Hydrocortisoni-17 Butyras 1 mg/g
Cheplapharm Schweiz
GmbH
B / SL
FB
G
Betamethason (D07AC01) 6 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Betnovate
30 g
3.23
12.75
10%
Crème: Betamethasonum 1 mg
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Diprosone
30 g
3.61
13.15
10%
Crème: Betamethasonum
Organon GmbH
B / SL
FB
G
FI
PI
Betnovate
30 g
3.23
12.75
10%
Salbe: Betamethasonum 1 mg
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Betnovate
20 ml
2.20
11.65
10%
Lotion: Betamethasonum 1 mg/g
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Betnovate Scalp
Application
30 ml
4.16
13.75
10%
Lösung: Betamethasonum 1 mg/g
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Betnovate Scalp
Application
100 ml
10.33
27.65
10%
Lösung: Betamethasonum 1 mg/g
GlaxoSmithKline AG
B / SL
FB
G
Fluocinonid (D07AC08) 2 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Topsym
15 g
2.06
11.45
10%
Crème: Fluocinonidum
Farmaceutica Teofarma
Suisse SA
B / SL
FB
G
FI
PI
Topsym
30 g
3.80
13.35
10%
Crème: Fluocinonidum
Farmaceutica Teofarma
Suisse SA
● 
B / SL
FB
G
Mometason (D07AC13) 13 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Monovo
35 g
6.36
16.15
10%
Almirall AG
B / SL
FB
G
FI
PI
Monovo
70 g
11.19
28.60
10%
Almirall AG
B / SL
FB
G
FI
PI
Elocom
30 g
4.94
14.60
10%
Organon GmbH
B / SL
FB
G
FI
PI
Elocom
50 g
7.30
17.15
10%
Organon GmbH
B / SL
FB
G
FI
PI
Ovixan 1 mg/g
30 g
4.93
14.60
10%
Crème: Mometasoni-17 Furoas 1 mg
Gebro Pharma AG
B / SL
FB
G
FI
PI
Ovixan 1 mg/g
100 g
13.97
31.60
10%
Crème: Mometasoni-17 Furoas 1 mg
Gebro Pharma AG
B / SL
FB
G
FI
PI
Elocom
30 g
4.94
14.60
10%
Organon GmbH
B / SL
FB
G
FI
PI
Elocom
50 g
7.30
17.15
10%
Organon GmbH
B / SL
FB
G
FI
PI
Elocom
30 ml
5.48
15.20
10%
Lösung: Mometasoni Furoas 1 mg/g
Organon GmbH
B / SL
FB
G
FI
PI
Elocom
100 ml
13.86
31.50
10%
Lösung: Mometasoni Furoas 1 mg/g
Organon GmbH
B / SL
FB
G
FI
PI
Monovo
30 g
7.34
16.65
k.A.
Almirall AG
B
FB
G
FI
PI
Monovo
50 g
10.86
20.65
k.A.
Almirall AG
B
FB
G
FI
PI
Monovo
90 g
PA
PA
k.A.
Almirall AG
B
FB
G
Methylprednisolonaceponat (D07AC14) 2 Präparate
WHO-DDD
FI
PI
Advantan
30 g
5.43
15.15
10%
Crème: Methylprednisoloni Aceponas 1 mg
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
FI
PI
Advantan
30 g
5.43
15.15
10%
Salbe: Methylprednisoloni Aceponas 1 mg
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
Fluticason (D07AC17) 1 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Cutivate
30 g
3.70
13.25
10%
Salbe: Fluticasoni Propionas 50 µg
GlaxoSmithKline AG
B / SL
FB
G
Prednicarbat (D07AC18) 15 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Prednicutan
30 g
3.88
13.45
10%
Crème: Prednicarbatum 2.5 mg
Dermapharm AG
B / SL
FB
G
FI
PI
Prednicutan
30 g
3.88
13.45
10%
Fettsalbe: Prednicarbatum 2.5 mg
Dermapharm AG
B / SL
FB
G
FI
PI
Prednicutan
30 g
3.88
13.45
10%
Salbe: Prednicarbatum 2.5 mg
Dermapharm AG
B / SL
FB
G
FI
PI
Prednicutan Crinale
50 ml
6.81
16.65
10%
Lösung: Prednicarbatum 2.5 mg/g
Dermapharm AG
B / SL
FB
G
FI
PI
Prednicutan
10 g
PA
PA
k.A.
Crème: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
50 g
PA
PA
k.A.
Crème: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
100 g
PA
PA
k.A.
Crème: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
10 g
PA
PA
k.A.
Fettsalbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
50 g
PA
PA
k.A.
Fettsalbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
100 g
PA
PA
k.A.
Fettsalbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
10 g
PA
PA
k.A.
Salbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
50 g
PA
PA
k.A.
Salbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan
100 g
PA
PA
k.A.
Salbe: Prednicarbatum 2.5 mg
Dermapharm AG
B
FB
G
FI
PI
Prednicutan Crinale
20 ml
PA
PA
k.A.
Lösung: Prednicarbatum 2.5 mg/g
Dermapharm AG
B
FB
G
FI
PI
Prednicutan Crinale
100 ml
PA
PA
k.A.
Lösung: Prednicarbatum 2.5 mg/g
Dermapharm AG
B
FB
G
Clobetasol (D07AD01) 10 Präparate
WHO-DDD
DrugBank.ca
FI
PI
Clobex
125 ml
14.70
32.25
10%
Galderma SA
B / SL / SO
FB
G
FI
PI
Clobetasol Leman 0.5mg/g
125 ml
12.50
30.00
10%
shampoing: Clobetasoli Propionas
Leman SKL SA
B / SL / SG
FB
G
FI
PI
Dermovate
30 g
3.54
13.10
10%
Crème: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Dermovate
100 g
9.69
26.95
10%
Crème: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Dermovate
30 g
3.54
13.10
10%
Salbe: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Dermovate
100 g
9.69
26.95
10%
Salbe: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Dermovate Scalp
Application
25 ml
4.10
13.70
10%
Lösung: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Dermovate Scalp
Application
100 ml
13.16
30.75
10%
Lösung: Clobetasoli Propionas
GlaxoSmithKline AG
B / SL
FB
G
FI
PI
Clarelux
100 g
12.20
29.70
10%
Schaum zur Anwendung auf der Haut: Clobetasoli Propionas
Pierre Fabre Pharma SA
B / SL
FB
G
FI
PI
Clarelux
50 g
7.10
16.35
k.A.
Schaum zur Anwendung auf der Haut: Clobetasoli Propionas
Pierre Fabre Pharma SA
B
FB
G
Arzneimittel A-Z
|
ATC-Browser
|
Neuregistrierungen
2025
©ywesee GmbH
Einstellungen
|
Hilfe
|
FAQ
|
Anmeldung
|
Kontakt
|
Home